Medicilon has over 100 well-characterized Tumor Cell Line Xenograft models. Our experienced staffs operate with strong theoretical basis. We offer the services which are flexible for custom development of various types of models to meet the requirements of our clients.
Xenograft Models
Cancer Type | Human Cancer Cell Lines |
Head and Neck | FaDu, Detroit 562, CAL-27 |
Oral Epithelial Carcinoma | KB |
Lung Cancer | DMS114, NCI-H69, NCl-H146, NCl-H209, NCI-H446, NCI-H526, NCI-H1688, 95-D, A549, Calu-1, Calu-3, Calu-6, HCC827, NCI-H226, NCI-H292, NCI-H358, NCI-H441, NCI-H460, NCI-H520, NCI-H522, NCI-H1299, NCI-H1437, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2009, NCI-H2122, NCI-H2126, NCI-H2228, PC-10, QG-56, A427, H23, H1568, H2110 |
Breast Cancer | SUM159, MDA-MB-231, MDA-MB-468, Bcap-37, 2LMP, ZR-75-1, ZR-75-30, HCC70, HCC1954, MDA-MB-361, MCF-7, BT474 |
Gastric Cancer | MKN-45, NCI-N87, BGC-823, HGC-27, MKN-28, NUGC-3, SCH, SGC-7901, SNU-5, SNU-16, MGC-803 |
Pancreatic Cancer | AsPC-1, BxPC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II, MIAPaCa-2, PANC-1, PANC-10.05 |
Renal Cancer | ACHN, OS-RC-2, 786-O, A498 |
Hepatocellular Carcinoma | Bel-7402, Hep-3B, Huh-7, PLC/PRF/5, QGY-7703, SK-HEP-1, SMMC-7721, HepG-2, JHH7 |
Glioblastoma | U87-MG |
Colon and Cecum Cancer | COLO 201, COLO 205, COLO 320 DM, CW-2, DLD-1, HCT-8, HCT-15, HCT-116, HT-29, LoVo, LS1034, LS174T, LS411N, NCI-H716, RKO , SW48, SW620, WiDr, SW948, DiFi |
Prostate Cancer | DU145,PC-3, LNCap, CL-1, |
Urinary Bladder | HT-1197, HT-1376, RT4, SCaBER, SW780, T24 |
Ovary Cancer | ES-2, HO-8910PM, PA-1, SK-OV-3, OVCAR-3 |
Endometrium/
Hysterocarcinoma |
AN3 CA, HEC-1-A, ME-180, MFE-280 |
Cervical cancer | SiHa, Hela |
Skin Cancer | A431, Colo829 |
Melanoma | A375, A2058, C32, HMCB, SK-MEL-30, MDA-MB-435s, WM-226-4 |
Osteosarcoma | MG-63, SJSA-1 |
Fibrosarcoma | HT-1080 |
Muscle, Striated | SJCRH30 |
Myeloma | KMS-11, KMS-26, RPMI-8226 ,MM.1S |
Leukemia / Lymphoma | U937, THP-1, MV-4-11, HEL, TF-1a, ML-2, HL-60, K562, KARPAS-299, Daudi, RL, Mino, Raji, Ramos, ARH-77, KMS-12-BM, KG-1, JeKo-1, MAVER-1, CML-T1, MOLM-13, TMD-8, OCI-LY10, Nalm-6 |
Tumor Cell Line Xenograft models is valuable for predicting cytotoxicity of cancer drugs and widely used in efficacy studies for its simplicity and easy access to tumor measurement. Medicilon currently offers a large range of Xenograft models derived from human cancer cell lines.